Uncovering repurposed medicines to fight liver fibrosis
Stanford geneticist uses Co-Scientist to identify repurposed drugs for liver fibrosis. This AI-powered approach accelerates the discovery of novel treatments for chronic liver disease, a significant unmet medical need.